Owen Daniel R, Sun Yilun, Irrer Jim C, Schipper Matthew J, Schonewolf Caitlin A, Galbán Stefanie, Jolly Shruti, Haken Randall K Ten, Galbán C J, Matuszak M M
Departments of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Departments of Biostatistics, University of Michigan, Ann Arbor, Michigan.
Adv Radiat Oncol. 2022 Apr 25;7(4):100980. doi: 10.1016/j.adro.2022.100980. eCollection 2022 Jul-Aug.
Parametric response mapping (PRM) of high-resolution, paired inspiration and expiration computed tomography (CT) scans is a promising analytical imaging technique that is currently used in diagnostic applications and offers the ability to characterize and quantify certain pulmonary pathologies on a patient-specific basis. As one of the first studies to implement such a technique in the radiation oncology clinic, the goal of this work was to assess the feasibility for PRM analysis to identify pulmonary abnormalities in patients with lung cancer before radiation therapy (RT).
High-resolution, paired inspiration and expiration CT scans were acquired from 23 patients with lung cancer as part of routine treatment planning CT acquisition. When applied to the paired CT scans, PRM analysis classifies lung parenchyma, on a voxel-wise basis, as normal, small airways disease (SAD), emphysema, or parenchymal disease (PD). PRM classifications were quantified as a percent of total lung volume and were evaluated globally and regionally within the lung.
PRM analysis of pre-RT CT scans was successfully implemented using a workflow that produced patient-specific maps and quantified specific phenotypes of pulmonary abnormalities. Through this study, a large prevalence of SAD and PD was demonstrated in this lung cancer patient population, with global averages of 10% and 17%, respectively. Moreover, PRM-classified normal and SAD in the region with primary tumor involvement were found to be significantly different from global lung values. When present, elevated levels of PD and SAD abnormalities tended to be pervasive in multiple regions of the lung, indicating a large burden of underlying disease.
Pulmonary abnormalities, as detected by PRM, were characterized in patients with lung cancer scheduled for RT. Although further study is needed, PRM is a highly accessible CT-based imaging technique that has the potential to identify local lung abnormalities associated with chronic obstructive pulmonary disease and interstitial lung disease. Further investigation in the radiation oncology setting may provide strategies for tailoring RT planning and risk assessment based on pre-existing PRM-based pathology.
高分辨率吸气与呼气配对计算机断层扫描(CT)的参数反应映射(PRM)是一种很有前景的分析成像技术,目前用于诊断应用,能够在个体患者基础上对某些肺部病变进行特征描述和量化。作为在放射肿瘤学临床中实施这种技术的首批研究之一,本研究的目的是评估PRM分析在放疗(RT)前识别肺癌患者肺部异常的可行性。
作为常规治疗计划CT采集的一部分,从23例肺癌患者中获取高分辨率吸气与呼气配对CT扫描。当应用于配对CT扫描时,PRM分析在体素水平上将肺实质分类为正常、小气道疾病(SAD)、肺气肿或实质疾病(PD)。PRM分类以占肺总体积的百分比进行量化,并在肺内进行整体和区域评估。
使用生成个体患者图谱并量化肺部异常特定表型的工作流程,成功地对放疗前CT扫描进行了PRM分析。通过本研究,在该肺癌患者群体中证实了SAD和PD的高患病率,全球平均值分别为10%和17%。此外,发现原发肿瘤累及区域PRM分类的正常和SAD与全肺值有显著差异。当存在时,PD和SAD异常水平升高往往在肺的多个区域普遍存在,表明潜在疾病负担较重。
计划接受放疗的肺癌患者中,PRM检测到的肺部异常得到了特征描述。尽管还需要进一步研究,但PRM是一种极易获得的基于CT的成像技术,有潜力识别与慢性阻塞性肺疾病和间质性肺疾病相关的局部肺部异常。在放射肿瘤学环境中的进一步研究可能会提供基于预先存在的PRM病理学来定制放疗计划和风险评估的策略。